---
figid: PMC1892626__RIU009002_0047_fig003
figlink: /pmc/articles/PMC1892626/figure/F3/
number: F3
caption: Regulation of hypoxia-inducible factor-1α (HIF-1α) and drug interventions
  currently in use. Activation of receptor tyrosine kinase (RTK), such as Rous Sarcoma
  oncogene (SRC) and the human epidermal growth factor receptor 2 (HER2), insulinlike
  growth factor (IGF), and epidermal growth factor (EGF) receptors, stimulate the
  PI3K-AKT-mTOR pathway. These pathways lead to the phosphorylation of S6 kinase and
  4E-BP1. S6 kinase and 4E-BP1 lead to the translation of HIF-1α messenger RNA (mRNA).
  The hypoxia-induced pathway is linked to the VHL dysfunction in renal cell carcinoma
  (RCC). HIF regulates the expression of an array of genes that encode proteins regulating
  angiogenesis, pH, metastatic spread, tumor growth, and glucose transport. The drugs
  currently preferred for the targeted treatment of metastatic RCC are depicted here.
  ATP, adenosine triphosphate; EGFR, EGF receptor; mTOR, mammalian target of rapamycin;
  PDGF, platelet-derived growth factor; PDGFR, PDGF receptor; PI3K, phosphoinositide
  3-kinase, TGF-α, transforming growth factor-α; VEGF, vascular endothelial growth
  factor; VEGFR, VEGF receptor.
pmcid: PMC1892626
papertitle: 'Understanding the Natural Biology of Kidney Cancer: Implications for
  Targeted Cancer Therapy.'
reftext: Tobias Klatte, et al. Rev Urol. 2007 Spring;9(2):47-56.
pmc_ranked_result_index: '77459'
pathway_score: 0.9525501
filename: RIU009002_0047_fig003.jpg
figtitle: Regulation of hypoxia-inducible factor-1A (HIF-1A) and drug interventions
  currently in use
year: '2007'
organisms: Homo sapiens
ndex: 483a7bdc-dee9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC1892626__RIU009002_0047_fig003.html
  '@type': Dataset
  description: Regulation of hypoxia-inducible factor-1α (HIF-1α) and drug interventions
    currently in use. Activation of receptor tyrosine kinase (RTK), such as Rous Sarcoma
    oncogene (SRC) and the human epidermal growth factor receptor 2 (HER2), insulinlike
    growth factor (IGF), and epidermal growth factor (EGF) receptors, stimulate the
    PI3K-AKT-mTOR pathway. These pathways lead to the phosphorylation of S6 kinase
    and 4E-BP1. S6 kinase and 4E-BP1 lead to the translation of HIF-1α messenger RNA
    (mRNA). The hypoxia-induced pathway is linked to the VHL dysfunction in renal
    cell carcinoma (RCC). HIF regulates the expression of an array of genes that encode
    proteins regulating angiogenesis, pH, metastatic spread, tumor growth, and glucose
    transport. The drugs currently preferred for the targeted treatment of metastatic
    RCC are depicted here. ATP, adenosine triphosphate; EGFR, EGF receptor; mTOR,
    mammalian target of rapamycin; PDGF, platelet-derived growth factor; PDGFR, PDGF
    receptor; PI3K, phosphoinositide 3-kinase, TGF-α, transforming growth factor-α;
    VEGF, vascular endothelial growth factor; VEGFR, VEGF receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFRA
  - MTOR
  - MAPK13
  - HIF1A
  - VHL
  - MAPK9
  - MAPK10
  - PIK3CB
  - MAPK11
  - MAPK8
  - MAPK1
  - KDR
  - TGFA
  - MAPK3
  - ARNTL
  - PDGFRB
  - NRAS
  - ARNT
  - MAPK14
  - KRAS
  - PIK3CD
  - EPAS1
  - HIF3A
  - PDGFC
  - HRAS
  - PIK3CA
  - PIK3R3
  - RAF1
  - PDGFA
  - ARNT2
  - PTEN
  - SLC2A1
  - BRAF
  - AKT3
  - FLT4
  - PIK3CG
  - VEGFB
  - FLT1
  - PIK3R5
  - EGFR
  - CXCR4
  - ARAF
  - EGF
  - MAPK12
  - PIK3R6
  - VEGFA
  - PIK3R4
  - AKT2
  - CA9
  - PDGFD
  - PDGFB
  - VEGFC
  - PGF
  - VEGFD
  - AKT1
  - Temsirolimus
  - Glucose
  - Cancer
  - Lung cancer
genes:
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAS/RAF/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: VHL
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: RAS/RAF/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: RAS/RAF/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAS/RAF/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: RAS/RAF/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: RAS/RAF/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: TGF-a
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: RAS/RAF/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: RAS/RAF/MAPK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: RAS/RAF/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: RAS/RAF/MAPK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: VEGF/PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: RAS/RAF/MAPK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAS/RAF/MAPK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: VEGF/PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: GLUT-1
  symbol: GLUT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: RAS/RAF/MAPK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: VEGF/PDGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: CXCR4
  symbol: CXCR4
  source: hgnc_symbol
  hgnc_symbol: CXCR4
  entrez: '7852'
- word: RAS/RAF/MAPK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: •EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: RAS/RAF/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: VEGF/PDGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CAIX/XII
  symbol: CAIX
  source: hgnc_alias_symbol
  hgnc_symbol: CA9
  entrez: '768'
- word: VEGF/PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: VEGF/PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: VEGF/PDGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF/PDGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF/PDGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Glucose
  source: MESH
  identifier: D005947
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC1892626__F3
redirect_from: /figures/PMC1892626__F3
figtype: Figure
---
